Lantheus (LNTH) Trading Up 10.1% Following Earnings Beat

Lantheus Holdings Inc (NASDAQ:LNTH) was up 10.1% during trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $15.33 and last traded at $13.97. Approximately 795,503 shares changed hands during trading, an increase of 121% from the average daily volume of 359,379 shares. The stock had previously closed at $12.69.

The medical equipment provider reported $0.24 EPS for the quarter, beating the consensus estimate of $0.18 by $0.06. Lantheus had a return on equity of 97.39% and a net margin of 36.75%. The company had revenue of $88.90 million for the quarter, compared to analyst estimates of $83.53 million. During the same period last year, the company earned $0.24 earnings per share. Lantheus’s quarterly revenue was up 11.1% compared to the same quarter last year.

Several analysts have commented on LNTH shares. ValuEngine raised Lantheus from a “sell” rating to a “hold” rating in a report on Monday, August 20th. Wells Fargo & Co dropped their price objective on Lantheus from $26.00 to $20.00 and set an “outperform” rating on the stock in a report on Thursday, August 2nd. BidaskClub lowered Lantheus from a “buy” rating to a “hold” rating in a research note on Tuesday, September 25th. Zacks Investment Research lowered Lantheus from a “hold” rating to a “sell” rating in a research note on Saturday, August 4th. Finally, Credit Suisse Group lowered their price target on Lantheus from $23.00 to $21.00 and set a “neutral” rating on the stock in a research note on Thursday, August 2nd. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $23.75.

Large investors have recently modified their holdings of the company. Itau Unibanco Holding S.A. acquired a new stake in shares of Lantheus in the second quarter worth approximately $104,000. Piedmont Investment Advisors LLC acquired a new stake in shares of Lantheus in the second quarter worth approximately $104,000. NumerixS Investment Technologies Inc boosted its stake in shares of Lantheus by 1,000.0% in the second quarter. NumerixS Investment Technologies Inc now owns 7,700 shares of the medical equipment provider’s stock worth $113,000 after acquiring an additional 7,000 shares during the last quarter. Sun Life Financial INC acquired a new stake in shares of Lantheus in the second quarter worth approximately $140,000. Finally, SG Americas Securities LLC acquired a new stake in shares of Lantheus in the second quarter worth approximately $151,000. 92.62% of the stock is currently owned by hedge funds and other institutional investors.

The company has a debt-to-equity ratio of 5.94, a current ratio of 3.86 and a quick ratio of 3.14. The company has a market capitalization of $486.03 million, a PE ratio of 14.67, a P/E/G ratio of 2.92 and a beta of 1.32.

About Lantheus (NASDAQ:LNTH)

Lantheus Holdings, Inc develops, manufactures, and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases worldwide. Its principal products include DEFINITY, an ultrasound contrast agent used in ultrasound exams of the heart; TechneLite, a technetium generator that provides the essential nuclear material used in nuclear medicine procedures; and Xenon, a radiopharmaceutical gas used to assess pulmonary function and imaging cerebral blood flow.

Further Reading: What are the economic characteristics of a bear market?

Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply